Cover Image
市場調查報告書

Argos Therapeutics, Inc.:產品平台分析

Argos Therapeutics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 219733
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
Argos Therapeutics, Inc.:產品平台分析 Argos Therapeutics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 36 Pages
簡介

Argos Therapeutics, Inc. ha,是開發並商品化治療感染疾病及腫瘤的免疫療法之生物製藥公司。

本報告提供Argos Therapeutics, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Argos Therapeutics, Inc.的基本資料

  • Argos Therapeutics, Inc.概要
  • 主要資訊
  • 企業資料

Argos Therapeutics, Inc.:R&D概要

  • 主要的治療範圍

Argos Therapeutics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Argos Therapeutics, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Argos Therapeutics, Inc.:藥物簡介

  • rocapuldencel-t
  • AGS-004
  • AGS-009
  • AGS-010

Argos Therapeutics, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Argos Therapeutics, Inc.:最近的開發平台趨勢

Argos Therapeutics, Inc.:暫停中的計劃

Argos Therapeutics, Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • AGS-004
    • MB-002
    • rocapuldencel-t

Argos Therapeutics, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07492CDB

Summary

Global Markets Direct's, 'Argos Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Argos Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Argos Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Argos Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Argos Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Argos Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Argos Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Argos Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Argos Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Argos Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Argos Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Argos Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Argos Therapeutics, Inc. Snapshot
    • Argos Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Argos Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Argos Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Argos Therapeutics, Inc. - Pipeline Products Glance
    • Argos Therapeutics, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Argos Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Argos Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Argos Therapeutics, Inc. - Drug Profiles
    • rocapuldencel-t
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AGS-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AGS-009
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AGS-010
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Argos Therapeutics, Inc. - Pipeline Analysis
    • Argos Therapeutics, Inc. - Pipeline Products by Target
    • Argos Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Argos Therapeutics, Inc. - Pipeline Products by Molecule Type
    • Argos Therapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Argos Therapeutics, Inc. - Recent Pipeline Updates
  • Argos Therapeutics, Inc. - Dormant Projects
  • Argos Therapeutics, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • AGS-004
      • MB-002
      • rocapuldencel-t
  • Argos Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Argos Therapeutics, Inc., Key Information
  • Argos Therapeutics, Inc., Key Facts
  • Argos Therapeutics, Inc. - Pipeline by Indication, 2015
  • Argos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Argos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Argos Therapeutics, Inc. - Phase III, 2015
  • Argos Therapeutics, Inc. - Phase II, 2015
  • Argos Therapeutics, Inc. - Phase I, 2015
  • Argos Therapeutics, Inc. - Preclinical, 2015
  • Argos Therapeutics, Inc. - Pipeline by Target, 2015
  • Argos Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Argos Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Argos Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Argos Therapeutics, Inc. - Recent Pipeline Updates, 2015
  • Argos Therapeutics, Inc. - Dormant Developmental Projects,2015
  • Argos Therapeutics, Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Argos Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Argos Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Argos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Argos Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
  • Argos Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Argos Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Argos Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top